Novio Catalpa Video
https://www.youtube.com/watch?v=MFwyRKLTx0Y
https://www.youtube.com/watch?v=MFwyRKLTx0Y
Novio Catalpa Presentation – Prof. Ger Pruijn Ger Pruijn, Professor of Autoimmune Diseases at Radboud University, will present the Novio Catalpa solution during an international scientific conference session focused on novel frontiers in rheumatoid arthritis. In his presentation, Prof. Pruijn will introduce a nanobody-based hemagglutination assay for the rapid detection of [...]
Your Content Goes Here One of the 30 most promising innovations among all Eurostars submissions in 2025. The Novio Catalpa consortium has been selected as one of the 30 most promising innovations among all Eurostars submissions in 2025. The grant will be used to further develop our platform technology for the [...]
Novio Catalpa will present at the 17th Dresden Symposium of Autoantibodies The 17th Dresden Symposium on Autoantibodies will take place from September 9 to September 12, at the Dresden Fair, Germany. The congress is entitled: The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease. This four-day event will feature recent findings from leading industrial, [...]
Published in 'Rheumatology Advances in Practice'
Your Content Goes Here Presentation among world-leading experts at the EMBO Workshop Our Advisory Board member Prof. Dr. Ger Pruijn will be one of the speakers at the EMBO Workshop from 8 to 11 July in Toulouse. He was invited following the selection of the Abstract: ‘Rapid detection of anti-citrullinated protein [...]
KIEM GoChem grant to step up development KIEM GoChem grant to step up development The collaboration between Novio Catalpa and the HAN BioCentre, Centre of Expertise in Applied Biosciences and Chemistry, was further strengthened. The HAN BioCentre has been awarded a KIEM GoChem grant for sustainable innovation in chemistry. This [...]
Collaboration with HAN BioCentre Novio Catalpa has established a collaboration with HAN BioCentre, a Centre of Expertise in Applied Biosciences and Chemistry. The collaboration aims to develop and manufacture Novio Catalpa’s diagnostic nanobodies for a rapid agglutination assay that will offer an innovative approach in Rheumatoid Arthritis diagnosis. HAN BioCentre will [...]
Published in 'Nature Reviews Rheumatology'.
Published in ‘Frontiers in Immunology'